Spots Global Cancer Trial Database for gemcitabine and cisplatin plus sorafenib
Every month we try and update this database with for gemcitabine and cisplatin plus sorafenib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma | NCT00714948 | Bladder Cancer URINARY BLADDER | gemcitabine and... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma | NCT00714948 | Bladder Cancer URINARY BLADDER | gemcitabine and... | 18 Years - | Memorial Sloan Kettering Cancer Center |